ANL
Price
$1.73
Change
-$0.04 (-2.26%)
Updated
Oct 3 closing price
Capitalization
63.84M
58 days until earnings call
NVCT
Price
$6.00
Change
-$0.06 (-0.99%)
Updated
Oct 3 closing price
Capitalization
152.87M
36 days until earnings call
Interact to see
Advertisement

ANL vs NVCT

Header iconANL vs NVCT Comparison
Open Charts ANL vs NVCTBanner chart's image
Adlai Nortye
Price$1.73
Change-$0.04 (-2.26%)
Volume$2.21K
Capitalization63.84M
Nuvectis Pharma
Price$6.00
Change-$0.06 (-0.99%)
Volume$42.33K
Capitalization152.87M
ANL vs NVCT Comparison Chart in %
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. NVCT commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and NVCT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ANL: $1.73 vs. NVCT: $6.01)
Brand notoriety: ANL and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 22% vs. NVCT: 42%
Market capitalization -- ANL: $63.84M vs. NVCT: $152.87M
ANL [@Biotechnology] is valued at $63.84M. NVCT’s [@Biotechnology] market capitalization is $152.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 2 TA indicator(s) are bullish while NVCT’s TA Score has 3 bullish TA indicator(s).

  • ANL’s TA Score: 2 bullish, 4 bearish.
  • NVCT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, NVCT is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а +0.58% price change this week, while NVCT (@Biotechnology) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ANL is expected to report earnings on Dec 03, 2025.

NVCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($153M) has a higher market cap than ANL($63.8M). NVCT YTD gains are higher at: 10.998 vs. ANL (-35.573). NVCT has higher annual earnings (EBITDA): -22.97M vs. ANL (-49.89M). ANL has more cash in the bank: 98M vs. NVCT (26.8M). ANL has higher revenues than NVCT: ANL (5M) vs NVCT (0).
ANLNVCTANL / NVCT
Capitalization63.8M153M42%
EBITDA-49.89M-22.97M217%
Gain YTD-35.57310.998-323%
P/E RatioN/AN/A-
Revenue5M0-
Total Cash98M26.8M366%
Total Debt39.5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ANLNVCT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AASP5.480.28
+5.38%
Agassi Sports Entertainment Corp.
NAHD0.01N/A
N/A
New Asia Holdings, Inc.
PMOIF2.69N/A
N/A
Harbour Energy Plc
QBEIF13.71N/A
N/A
QBE Insurance Group Ltd.
SLOFF3.01N/A
N/A
Solstad Farstad ASA

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.54%
FGHQF - ANL
25%
Poorly correlated
N/A
MOLN - ANL
23%
Poorly correlated
+0.02%
NVCT - ANL
21%
Poorly correlated
-1.07%
JAZZ - ANL
21%
Poorly correlated
+1.65%
VCEL - ANL
21%
Poorly correlated
+2.92%
More

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-1.07%
PDSB - NVCT
32%
Poorly correlated
N/A
ADMA - NVCT
30%
Poorly correlated
+0.89%
SGMT - NVCT
28%
Poorly correlated
+1.82%
ZLAB - NVCT
26%
Poorly correlated
-0.30%
AGIO - NVCT
26%
Poorly correlated
+1.43%
More